Methocarbamol
Centrally acting muscle relaxant for short-term back pain.
- Starts working
- 30 minutes
- Half-life
- 1–2 hours
- In use since
- —
- Pregnancy
- Use with caution
Overview
Methocarbamol relieves painful muscle spasms in the short term. It is milder than diazepam or tizanidine but can make you drowsy.
Conditions it's used for
How it works
Eases painful muscle spasm.
Methocarbamol belongs to the Muscle relaxants. How Muscle relaxants work: turn down the spinal reflexes that keep muscles tight.
Uses
- Acute painful musculoskeletal conditions
Available as: tablet, iv injection.
Typical dose
- Adults
- 1.5 g four times a day for 2–3 days, then 1 g four times a day.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Drowsiness
- Dizziness
- Nausea
- Blurred vision
Serious — get medical help
Uncommon, but need prompt attention
- Allergic reaction (rare)
- Low blood pressure with IV
Warnings
- Short-term use
Who should avoid it
- Allergy to methocarbamol
- Kidney impairment (injection)
Interactions
- Alcohol and sedatives — drowsiness
Other medicines in the atlas that need care with Methocarbamol, grouped by the reason:
Dangerous drowsiness and slowed breathingMajorWith Buprenorphine, Codeine, Fentanyl, Hydromorphone, Methadone and 6 more
Opioids combined with other opioids, benzodiazepines, gabapentinoids, sleeping tablets or sedating medicines can stop breathing. Many fatal overdoses involve such combinations.
What's usually done: Avoid unless prescribed together with a clear plan. Use the lowest doses, avoid alcohol, and keep naloxone available.
Added sedationModerateWith Alprazolam, Amisulpride, Amitriptyline, Aripiprazole, Baclofen and 47 more
Both medicines cause drowsiness; together they impair driving, balance and breathing, especially in older people.
What's usually done: Avoid driving until you know the effect; take extra care with alcohol and falls.
Using it safely
- Alcohol
- Best avoided. Alcohol adds to drowsiness.
- Food and drink
- With or without food.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Can be stopped.
- Driving
- Drowsiness; avoid driving.
- Tests and checks
- Not needed
- If too much is taken
- Drowsiness, low blood pressure. Seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Limited data; avoid unless needed.
Breastfeeding
Use with caution
Small amounts in milk.
Special groups
- Kidney disease
- Avoid IV in kidney impairment.
- Liver disease
- Use caution.
- Older adults
- Use caution.
Brand names
- United States
- Robaxin
- United Kingdom
- Robaxin (discontinued)
- India
- Robaxin, Methocarbamol (generic)
- Australia
- Robaxin (limited)
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Methocarbamol?
Yes — Methocarbamol is prescription-only in most countries.
Can I take Methocarbamol during pregnancy?
Use with caution. Limited data; avoid unless needed. Always check with a doctor or midwife.
How quickly does Methocarbamol work?
30 minutes.
Related medicines
Tizanidine
Alpha-2 muscle relaxant for spasticity.
RxMuscle relaxantsCyclobenzaprine
Tricyclic-related muscle relaxant for short-term back spasm.
RxMuscle relaxantsThiocolchicoside
Muscle relaxant with restricted use in Europe over seizure and fertility concerns.
RxMuscle relaxantsBaclofen
Relieves muscle stiffness in MS and spinal injury.
RxMuscle relaxantsDantrolene
Antidote for malignant hyperthermia; also an oral muscle relaxant.
RxWHOMuscle relaxantsEperisone
Muscle relaxant with vasodilator effect, used in Asia.
RxMuscle relaxants
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — M03BA03
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.